Literature DB >> 7519069

Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential?

D Collen1, H R Lijnen.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7519069

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  19 in total

1.  Current Clinical Experience with Staphylokinase in Arterial Thrombosis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

Review 2.  Molecular basis of thrombolytic therapy.

Authors:  H R Lijnen; D Collen
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

3.  Purification and characterization of a novel fibrinolytic protease from Fusarium sp. CPCC 480097.

Authors:  Bin Wu; Licheng Wu; Daijie Chen; Zhijun Yang; Minyu Luo
Journal:  J Ind Microbiol Biotechnol       Date:  2009-01-14       Impact factor: 3.346

4.  A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion.

Authors:  Peter Verhamme; Godelieve Goossens; Geert Maleux; Désiré Collen; Marguerite Stas
Journal:  J Thromb Thrombolysis       Date:  2007-02-03       Impact factor: 2.300

5.  Fibrin-targeted plasminogen activation by plasminogen activator, PadA, from Streptococcus dysgalactiae.

Authors:  Satish Singh; Timsy Bhando; Kanak L Dikshit
Journal:  Protein Sci       Date:  2014-04-05       Impact factor: 6.725

6.  Potential for a New Coronary Thrombolytic Plateau.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

7.  Function of the 90-loop (Thr90-Glu100) region of staphylokinase in plasminogen activation probed through site-directed mutagenesis and loop deletion.

Authors:  Govindan Rajamohan; Monika Dahiya; Shekhar C Mande; Kanak L Dikshit
Journal:  Biochem J       Date:  2002-07-15       Impact factor: 3.857

8.  Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis.

Authors:  Marissa H Braff; Amanda L Jones; Shawn J Skerrett; Craig E Rubens
Journal:  J Infect Dis       Date:  2007-03-15       Impact factor: 5.226

Review 9.  Thrombolytic agents in development.

Authors:  M Verstraete; H R Lijnen; D Collen
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

10.  Staphylokinase as a plasminogen activator component in recombinant fusion proteins.

Authors:  S J Szarka; E G Sihota; H R Habibi; S Wong
Journal:  Appl Environ Microbiol       Date:  1999-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.